It was a rough week for some big names on Wall Street. With markets closing early for Good Friday, trading activity was trimmed, but that didn't stop several large-cap stocks from taking a beating. The usual suspects were at play: earnings disappointments, analyst downgrades, and strategic moves that investors didn't quite love.
Let's start with the athletic wear giant. Nike, Inc. (NKE) saw its shares drop 14.29% after reporting third-quarter financial results. The real kicker? The company's fourth-quarter sales guidance came in below what analysts were expecting. When a company tells the market it expects to make less money than everyone thought, the stock tends to react poorly. Multiple analysts got the memo and lowered their price forecasts on the stock. It's a classic case of guidance mattering just as much as the actual earnings.
Not far behind was Texas Pacific Land Corporation (TPL), which decreased 14.30%. The company didn't have a specific headline event tied to its drop this week, but it joined the list of significant decliners nonetheless.
Next up, the food distribution behemoth. Sysco Corporation (SYY) slumped 13.56%. The company announced it will acquire Jetro Restaurant Depot. Acquisitions can be tricky—sometimes investors love them, sometimes they hate them. In this case, the market reaction was negative, and it wasn't alone in its skepticism. Multiple analysts also lowered their price forecasts on Sysco's stock following the news. It seems the deal didn't quite whet Wall Street's appetite.
Venture Global, Inc. (VG) had an even steeper fall, dropping 15.01% for the week. Kratos Defense & Security Solutions, Inc. (KTOS) decreased 9.95%, while natural gas producer EQT Corporation (EQT) slumped 11.48%.
Then there's the medical device maker. Boston Scientific Corporation (BSX) fell 9.32%. Here's where it gets interesting. The company announced data from its HI-PEITHO clinical trial evaluating the EKOS Endovascular System in patients with pulmonary embolism. The data was actually positive—EKOS demonstrated a 61% reduction in primary endpoint events. Good news, right? Not exactly. Raymond James downgraded its rating on the stock from Strong Buy to Outperform and lowered its price target from $97 to $88. Sometimes, even good clinical news isn't enough to keep analysts happy if their valuation models say otherwise.
Rogers Communication, Inc. (RCI) decreased 9.88% this week.
The story for MicroStrategy Inc. (MSTR) is a bit different. The company slumped 8.08%. But here's a twist: leading technical analyst Ali Martinez identified on Thursday the first "Buy" signal in months for MicroStrategy, potentially marking an end to its corrective phase. So, while the stock was down for the week, there might be a technical case building for a rebound. Technical analysis is its own world, but when a well-known analyst spots a signal, traders pay attention.
Rounding out the list, Antero Resources Corporation (AR) slumped 9.96%.
So, what's the takeaway? In a shortened week, the market still found plenty of reasons to sell. Earnings guidance, acquisition announcements, and analyst downgrades were the main drivers. For investors holding these names, it was a week to remember—or perhaps one they'd rather forget. The broader market closed with losses, and these ten stocks felt the brunt of it. Whether this is a temporary blip or the start of a longer trend for these companies remains to be seen, but for now, they're wearing the loser's cap.
